GEORGE J MORROW
CIK 1068754 · Exe VP, Global Commercial Ops · last filed 2026-05-29
GEORGE J MORROW is an Exe VP, Global Commercial Ops who has filed 91 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for NBIX, was dated May 29, 2026. Across all open-market trades the lifetime net is −$44.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $55.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$54.98M
7
91
-$44.37M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Director | 10,386 | $166.80 | $1.73M | -$7.73M | 16 | 2026-05-29 |
| ALGN | Director | 8,309 | $169.16 | $1.41M | -$32.74M | 30 | 2026-05-22 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Director | 3,907 | — | — | $123 | 6 | 2018-05-24 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 3 | 2017-07-14 |
| SAFEWAY INC (SWY) Delisted | Director | — | — | — | $0 | 14 | 2015-02-02 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Director | 0 | — | — | $157.9K | 5 | 2012-08-01 |
| AMGN | Exe VP, Global Commercial Ops | 134,606 | $385.16 | $51.85M | -$4.06M | 15 | 2010-04-30 |
Recent Filings
91 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2026-05-22 | ALGN | Exer (M) | +1,745 | $0 | EDGAR |
| 2026-05-21 | NBIX | Exer (M) | +3,318 | $0 | EDGAR |
| 2025-11-26 | NBIX | Mixed | — | -$1.43M | EDGAR |
| 2025-11-25 | NBIX | Notice (144) | −15,000 | -$2.12M | EDGAR |
| 2025-05-22 | ALGN | Mixed | +1,148 | $0 | EDGAR |
| 2025-05-22 | NBIX | Mixed | +2,869 | $0 | EDGAR |
| 2024-05-24 | ALGN | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2024-05-21 | ALGN | Exer (M) | +1,029 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.